Leprosy strategy is about control, not eradication

The Lancet

Volumn 371, Issue 9617, 2008, Pages 969-970

  Smith, Cairns ^a   Richardus, Jan Hendrik ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CLOFAZIMINE; DAPSONE; RIFAMPICIN;

ARTICLE; COMBINATION CHEMOTHERAPY; DISEASE CONTROL; DISEASE TRANSMISSION; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; LEPROSY; MONOTHERAPY; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL;

EID: 40749098461     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60433-X     Document Type: Note

References (12)

1. World Health Organization. Leprosy: global situation. Wkly Epidemiol Rec 77 (2002) 1-8
2. World Health Organization. Global strategy for further reducing the leprosy burden and sustaining leprosy control activities (plan period 2006-2010) (2005). http://www.novartisfoundation.org/platform/content/element/1750/GlobalStrategy.pdf (accessed Feb 14, 2008).
3. World Health Organization. Global leprosy situation, 2007. Wkly Epidemiol Rec 82 (2007) 225-232
4. Fine P. Leprosy: what is being "eliminated"?. Bull World Health Organ 85 (2007) 2
5. Centers for Disease Control and Prevention. Recommendations of the International Task Force for Disease Eradication. MMWR Recom Rep 42 (1993) 1-38
6. Leisinger KM. Making leprosy history. 17th International Leprosy Congress, Hyderabad, India, Jan 30 to Feb 4, 2008: L-3 (abstr).
7. Richardus J., and Habbema J. The impact of leprosy control on the transmission of M. leprae: is elimination being attained?. Lepr Rev 78 (2007) 330-337
8. Meima A., Smith W., van Oortmarssen G., Richardus J., and Habbema J. The future incidence of leprosy: a scenario analysis. Bull World Health Organ 82 (2004) 373-380
9. Setia M., Steinmaus C., Ho C., and Rutherford G. The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis 6 (2006) 162-170
10. Smith C., and Smith W. Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. J Infect 41 (2000) 137-142
11. Moet F., Oskam L., Faber R., Pahan D., and Richardus J. A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP. Lepr Rev 75 (2004) 376-388
12. Geluk A., and Ottenhoff T. HLA and leprosy in the pre and postgenomic eras. Hum Immunol 67 (2006) 439-445